Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already provide readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, but the description adds substantial behavioral context: data sources (SEC EDGAR/XBRL, FAERS), fiscal-year handling (e.g., AAPL Sep, NVDA Jan), sorted results by primary metric, and return format (paired data + pipeworx:// citation URIs). This fully discloses what happens during execution without contradicting annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense but every sentence serves a purpose: trigger phrases, scope limits, data sources, sorting, return format, and efficiency gain. It is front-loaded with the most important usage cues and avoids redundancy. Slightly long, but for a tool that replaces many sequential lookups, this detail is justified.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description correctly explains return values ('paired data + citation URIs') and behavioral guarantees (sorted results, fiscal-year correctness). It covers types, examples, size limits, and alternatives, making it complete for a complex comparison tool. No significant gaps remain.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although the input schema has 100% coverage with descriptions for both 'type' and 'values', the description enriches parameter meaning by specifying what each type returns: 'type="company" pulls LATEST 10-K revenue...' and 'type="drug" pulls FAERS adverse-event counts...' It also clarifies output sorting behavior, adding value beyond the schema's basic constraints.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: 'side-by-side comparison of 2–5 companies or drugs in ONE parallel call.' It enumerates trigger phrases like 'X vs Y' and 'rank these companies,' and distinguishes itself from single-entity lookups by noting it 'Replaces 8–15 sequential lookups.' This is a specific verb+resource with clear sibling differentiation.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage guidance is explicit: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' It defines when to use the tool (comparison, ranking, head-to-head queries) and provides conditional data specifics for company vs. drug types. This goes beyond implied usage and gives clear direction on prioritizing this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation1/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route questions to the same data sources, and the Polymarket family (polymarket_edges, polymarket_edge_tracker, polymarket_arbitrage, polymarket_fill_risk, polymarket_kalshi_spread) has blurred boundaries. Agents would struggle to pick the right one without reading every description carefully.

Naming Consistency2/5

Naming is mostly snake_case but follows no consistent verb_noun pattern. Verbs vary widely (ask_, get_, list_, search_, compare_, scan_, validate_, remember, recall, forget, subscribe, unsubscribe, discover, generate, resolve, suggest) and many tools are bare nouns (entity_profile, recent_alerts, polymarket_edges). The inconsistency makes the set feel ad hoc.

Tool Count2/5

34 tools is on the heavy side, and the count is inflated by many near-duplicate data-router and prediction-market tools. The server is named 'iconify' yet only 3 of 34 tools actually relate to icons, indicating poor scoping for the stated purpose.

Completeness2/5

For the icon domain, the surface is minimal (list, search, get) with no create/update/delete. For the broader data/prediction-market domain, there are significant gaps in lifecycle coverage (e.g., subscriptions have create/cancel but no pause/resume, and the memory tools lack namespacing). The mixed focus means no single domain is fully covered.